Follow the NORTHWEST BIOTHERAPEUTICS INC stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €295.8m. The latest transaction was disclosed on 1 December 2023 (Cession). Among the most active insiders: MALIK NAVID. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
NORTHWEST BIOTHERAPEUTICS INC es una empresa centrada en el desarrollo de tratamientos de inmunoterapia para el cáncer. Cotiza en el NASDAQ bajo el símbolo NWBO.